138 related articles for article (PubMed ID: 34193409)
41. Immunophenotype of Lacrimal Glands in Graves Orbitopathy: Implications for the Pathogenesis of Th1 and Th17 Immunity.
Huang Y; Wu Y; Zhang S; Lu Y; Wang Y; Liu X; Zhong S; Wang Y; Li Y; Sun J; Fang S; Zhou H
Thyroid; 2022 Aug; 32(8):949-961. PubMed ID: 35469435
[No Abstract] [Full Text] [Related]
42. Autophagy is involved in the initiation and progression of Graves' orbitopathy.
Yoon JS; Lee HJ; Chae MK; Lee EJ
Thyroid; 2015 Apr; 25(4):445-54. PubMed ID: 25687157
[TBL] [Abstract][Full Text] [Related]
43. The Potential Role of Osteopontin in the Pathogenesis of Graves' Ophthalmopathy.
Lou H; Wu LQ; Wang H; Wei RL; Cheng JW
Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):18. PubMed ID: 34546326
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic Effect of Curcumin, a Plant Polyphenol Extracted From Curcuma longae, in Fibroblasts From Patients With Graves' Orbitopathy.
Lee JS; Kim J; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4129-4140. PubMed ID: 31593984
[TBL] [Abstract][Full Text] [Related]
45. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic Effect of Protocatechuic Aldehyde in an In Vitro Model of Graves' Orbitopathy.
Byun JW; Hwang S; Kang CW; Kim JH; Chae MK; Yoon JS; Lee EJ
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4055-62. PubMed ID: 27494347
[TBL] [Abstract][Full Text] [Related]
47. Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts.
Virakul S; Dalm VA; Paridaens D; van den Bosch WA; Mulder MT; Hirankarn N; van Hagen PM; Dik WA
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5457-64. PubMed ID: 26284551
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic Effect of Resveratrol on Oxidative Stress in Graves' Orbitopathy Orbital Fibroblasts.
Kim CY; Lee HJ; Chae MK; Byun JW; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6352-61. PubMed ID: 26436888
[TBL] [Abstract][Full Text] [Related]
49. Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.
Khoo TK; Coenen MJ; Schiefer AR; Kumar S; Bahn RS
Thyroid; 2008 Dec; 18(12):1291-6. PubMed ID: 18976167
[TBL] [Abstract][Full Text] [Related]
50. Inhibitory effect of fucosylated chondroitin sulfate from the sea cucumber Acaudina molpadioides on adipogenesis is dependent on Wnt/β-catenin pathway.
Xu H; Wang J; Zhang X; Li Z; Wang Y; Xue C
J Biosci Bioeng; 2015 Jan; 119(1):85-91. PubMed ID: 24982018
[TBL] [Abstract][Full Text] [Related]
51. Thalidomide inhibits adipogenesis of orbital fibroblasts in Graves' ophthalmopathy.
Zhang C; Zhang X; Ma L; Peng F; Huang J; Han H
Endocrine; 2012 Apr; 41(2):248-55. PubMed ID: 22237514
[TBL] [Abstract][Full Text] [Related]
52. Orbital Fibroblasts From Graves' Orbitopathy Patients Share Functional and Immunophenotypic Properties With Mesenchymal Stem/Stromal Cells.
Brandau S; Bruderek K; Hestermann K; Görtz GE; Horstmann M; Mattheis S; Lang S; Eckstein A; Berchner-Pfannschmidt U
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6549-57. PubMed ID: 26457540
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
Choi YJ; Kim C; Choi EW; Lee SH; Chae MK; Jun HO; Kim BY; Yoon JS; Jang SY
PLoS One; 2022; 17(8):e0270416. PubMed ID: 35980936
[TBL] [Abstract][Full Text] [Related]
54. Neferine suppresses autophagy-induced inflammation, oxidative stress and adipocyte differentiation in Graves' orbitopathy.
Li H; Gao L; Min J; Yang Y; Zhang R
J Cell Mol Med; 2021 Feb; 25(4):1949-1957. PubMed ID: 33443817
[TBL] [Abstract][Full Text] [Related]
55. Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.
Virakul S; Somparn P; Pisitkun T; van der Spek PJ; Dalm VASH; Paridaens D; van Hagen PM; Hirankarn N; Palaga T; Dik WA
Front Endocrinol (Lausanne); 2020; 11():619989. PubMed ID: 33658982
[TBL] [Abstract][Full Text] [Related]
56. Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves' ophthalmopathy patients.
Shahida B; Johnson PS; Jain R; Brorson H; Åsman P; Lantz M; Planck T
Endocr Connect; 2019 Sep; 8(9):1230-1239. PubMed ID: 31394503
[TBL] [Abstract][Full Text] [Related]
57. MicroRNA-29 mediates TGFβ1-induced extracellular matrix synthesis by targeting wnt/β-catenin pathway in human orbital fibroblasts.
Tan J; Tong BD; Wu YJ; Xiong W
Int J Clin Exp Pathol; 2014; 7(11):7571-7. PubMed ID: 25550793
[TBL] [Abstract][Full Text] [Related]
58. Adipose tissue depot-specific differences in the regulation of hyaluronan production of relevance to Graves' orbitopathy.
Zhang L; Grennan-Jones F; Lane C; Rees DA; Dayan CM; Ludgate M
J Clin Endocrinol Metab; 2012 Feb; 97(2):653-62. PubMed ID: 22162480
[TBL] [Abstract][Full Text] [Related]
59. Role of microRNA-146a in regulation of fibrosis in orbital fibroblasts from patients with Graves' orbitopathy.
Jang SY; Park SJ; Chae MK; Lee JH; Lee EJ; Yoon JS
Br J Ophthalmol; 2018 Mar; 102(3):407-414. PubMed ID: 29101123
[TBL] [Abstract][Full Text] [Related]
60. Regulation of Wnt/β-catenin signaling by CCAAT/enhancer binding protein β during adipogenesis.
Chung SS; Lee JS; Kim M; Ahn BY; Jung HS; Lee HM; Kim JW; Park KS
Obesity (Silver Spring); 2012 Mar; 20(3):482-7. PubMed ID: 21760632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
